Skip to content

Clinical trials

Lymphoma trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Status: Unknown status Country / region: China Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20101
20121
20133
20146
20158
201616
20179
201810
201910
202010
202113
202216
202310
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status117

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University10
Chinese PLA General Hospital6
Southwest Hospital, China6
Ruijin Hospital4
Sun Yat-sen University4
Beijing Doing Biomedical Co., Ltd.3
Fudan University3
Hebei Senlang Biotechnology Inc., Ltd.3
Peking University Cancer Hospital & Institute3
Sinobioway Cell Therapy Co., Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma117
Leukemia25
Recurrence9
Lymphoma, B-Cell8
Multiple Myeloma7
Leukemia, B-Cell5
Leukemia, Lymphocytic, Chronic, B-Cell5
Neoplasms5
Lung Neoplasms4
Lymphoma, Extranodal NK-T-Cell4

Trials

Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.